Roots of remedies: Plants, people and pharmaceuticals

Chemistry and Industry (London)

Volumn , Issue 1, 1999, Pages

  Houghton, Peter J ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG DESIGN; DRUG FIRMS; WESTERN MEDICINES;

EID: 17144461272     PISSN: 00093068     EISSN: None     Source Type: Trade Journal    
DOI: None     Document Type: Article

References (27)

1. Farnsworth, N.R., 'The role of medicinal plants in drug development', in 'Natural products and drug development' (Eds P. Krogsgaard-Larsen, S.B. Christensen & H. Kofod), London: Baillière, Tindall and Cox, 1984, 8-98
2. O'Neill, M.J. & Lewis, J.A., 'The renaissance of plant research in the pharmaceutical industry', in 'Human medicinal agents from plants', (Eds A.D. Kinghorn & M.F. Balandrin), Washington DC: American Chemical Society, 1993, 48-55
3. Marles, R.J. & Farnsworth, N.R., 'Plants as sources of antidiabetic agents', in 'Economic and medicinal plant research' (Eds H. Wagner & N.R. Farnsworth), Volume 6, London: Academic Press, 1994, 149-87
4. Martin, G.J., 'Conservation and ethnobotanical exploration', in 'Ethnobotany and the search for new drugs', Ciba Foundation Symposium 185, Chichester: Wiley, 1994, 229-39
5. Evans, W.C., 'Trease and Evans' pharmacognosy', 14th edition, London: Saunders, 1996, 313-6; 354-7; 358-60; 397-400
6. Dewick, P.M., 'Medicinal natural products', Chichester: Wiley, 1997, 227-33; 274-6, 280-3; 336-8
7. Dewick, P.M., ibid, 302-4
8. Holmstedt, B., 'The ordeal bean of old Calabar: the pageant of Physostigma venosum', in 'Plants in the development of modern medicine' (Ed. T. Swain), Cambridge, MA: Harvard University Press, 1972, 303-60
9. Polinsky, R.J., Clinical Therapeutics, 1998, 20(4), 634-47
10. Hofmann, A., 'Ergot - a rich source of pharmacologically active substances', in 'Plants in the development of modern medicine' (Ed. T. Swain), Cambridge, MA: Harvard University Press, 1972, 235-60
11. Shu, Y.-Z., J. Nat. Prod., 1998, 61(8), 1053-71
12. Sheehan, M.P., et al, Lancet, 1992, 340, 13-7
13. White, N.J., Trans. Royal Soc. Trop. Med. Hygiene, 1994, 88 Suppl. 1, 3-4
14. Cox, P.A., 'The ethnobotanical approach to drug discovery: strengths and limitations', in 'Ethnobotany and the search for new drugs', Ciba Foundation Symposium 185, Chichester: Wiley, 1994, 25-35
15. Cardellina II, J.H., et al, 'National Cancer Institute intramural research on human immunodeficiency virus inhibitory and antitumour plant natural products', in 'Human medicinal agents from plants', (Eds A.D. Kinghorn & M.F. Balandrin), Washington DC: American Chemical Society, 1993, 218-27
16. Hartwell, J.L. 'Plants used against cancer. A survey', Lawrence, MA: Quarterman Publications, 1982
17. Stähelin, H. & von Wartburg, A., Cancer Res., 1991, 51, 5-11
18. Noble, R.L., Biochem. Cell. Biol., 1990, 68, 1344-51
19. de Souza, N., 'Human medicinal agents from plants' (Eds A.D. Kinghorn & M.F. Balandrin), ACS Symposium Series, 1993, 534, 331-40
20. Kattige, S.L., et al, US patent number 4900727, 1990
21. Sedlacek, H.H., et al. Int. J. Oncology, 1996, 9, 1143-68
22. McAlpine, D., Pharmaceutical Marketing, 1992, 4, 24-6
23. Kleijnen, J. & Knipschild, P., Br. J. Clin. Pharmacol., 1992, 34, 352-8
24. LeBars, P.L., et al, J. Am. Med. Assoc., 1997, 278, 1327-32
25. Grindley, J., Scrip, 1993, 30-2
26. Cantley, M.F., 'International instruments, intellectual property and the collaborative exploitation of genetic resources', in 'Phytochemical diversity' (Eds S. Wrigley, M. Hayes, R. Thomas & E. Chrystal), Cambridge: Royal Society of Chemistry, 1997, 141-57
27. Intellectual property rights, naturally derived bioactive compounds and resource conservation, J. Ethnopharmacology, 1996, 51, 1-333